Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
True Angle Medical develops biofeedback technology for dysphagia (swallowing difficulty) treatment and rehabilitation. The company's Mobili-T device provides objective measurement and monitoring for patients and clinicians managing swallowing disorders.
2 investors
Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
2 investors
Two Plus Fertility is a fertility and reproductive health service or platform. The specific page content does not provide details about the company's business model or services.
2 investors
TXP Medical develops and provides medical data systems for emergency, intensive care, and emergency-services settings (the NEXT Stage ER series) as well as an oncology research data system, along with a medical data platform, real-world data analysis, and clinical research support. The company, based in Tokyo, Japan, aims to integrate fragmented hospital medical data into connected clinical datasets for use in care, research, and healthcare policy.
2 investors
Tybrhealth develops the B3 GELโข System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
2 investors
Ubenwa develops AI technology that analyzes newborn cries to assess infant needs and provide caregivers with insights, available through lightweight integrations into consumer devices and a mobile app called Nanni AI.
2 investors
Ultherapy develops FDA-cleared ultrasound devices that use microfocused ultrasound and real-time imaging to lift skin and stimulate collagen production without surgery. The company offers non-invasive aesthetic treatments for consumers seeking skin lifting and wrinkle reduction.
2 investors
Ultragenyx is a biotechnology company focused on developing treatments for patients living with rare genetic diseases. The company emphasizes a culture of generosity, curiosity, and inclusion among its team members.
2 investors
uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.
2 investors
Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.
2 investors
United Family Healthcare (ๅ็ฆๅฎถๅป็) is a private healthcare provider operating hospitals and clinics that offer patient-centered medical services across the full life cycle, including preventive care, diagnosis, treatment, and rehabilitation. It serves patients in China with an evidence-based clinical approach.
2 investors
The company builds technology focused on improving patient outcomes in healthcare.
2 investors
Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation. It runs a discovery organization in Boulder, Colorado, aiming to create treatments for patients with unmet medical needs.
2 investors
Nanox.AI develops an AI algorithm that analyzes CT scans to detect and measure fatty liver disease by assessing liver density, enabling radiologists to identify patients at risk for nonalcoholic fatty liver disease and associated cardiovascular complications. The solution integrates with existing medical imaging systems to support early detection and clinical decision-making in radiology practices and healthcare settings.
2 investors
Zener manufactures a ceiling-mounted far-UV disinfection device for operating rooms designed to reduce surgical site infections by increasing air changes and eliminating airborne bacteria during surgery. The device uses SafeRay technology (222 nm far-UV light) that provides bactericidal efficacy without the safety risks associated with traditional UV light.
2 investors
Vaderis develops a first-of-its-kind oral therapy for hereditary hemorrhagic telangiectasia (HHT), a rare vascular disease with no existing approved treatments. The company is led by scientists and clinicians focused on creating therapeutic options for patients with underserved rare diseases.
2 investors
VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patientsโparticularly womenโwho experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.
2 investors
VALD provides measurement and monitoring systems for assessing musculoskeletal performance across strength, movement, speed, and balance in athletic and rehabilitation settings. The company offers integrated hardware sensors and a centralized platform called VALD Hub for data management and athlete performance tracking.
2 investors
Valinor Discovery generates patient-derived datasets combining multi-omics and clinical data to enable machine learning applications in drug development. The company collects longitudinal data across molecular and imaging assays to create virtual patient profiles for pharmaceutical research.
2 investors
Valisure is a private company that accepts investment from venture capital firms, family offices, and individual accredited investors.
2 investors
Vatica Health develops software solutions for primary care physicians, health plans, and providers to improve the Medicare Annual Wellness Visit and risk adjustment processes. The platform enhances care quality, financial performance, and compliance while helping care teams work together to achieve better patient outcomes.
2 investors
VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.
2 investors
Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.
2 investors
Vena Medical develops medical devices for neuro-interventional applications, founded by mechanical engineering graduates. The company focuses on vascular and interventional neurology solutions.
2 investors